Review explores photobiomodulation effects in various health conditions, indicating its safety and efficacy.
Photobiomodulation (PBM), a form of nonthermal light therapy utilizing nonionizing light in the visible, near-infrared, or infrared spectra, has both direct effects (at the level of the mitochondria, the primary chromophore in humans) and indirect effects (via modulation of downstream signal transduction and cellular responses). As a result, it is thought to stimulate energy production, reduce oxidative stress, and decrease inflammation. PBM has been clinically studied in a large number of conditions and disease states, and has the advantage of being generally safe and cost-effective. The effects of PBM in autoimmunity, fibromyalgia, muscular function, neurological conditions, long COVID-19, carpal tunnel syndrome, radiation dermatitis, and oral mucositis are reviewed in this article, and additional opportunities for research are identified.
No takes yet. Share an insight, caveat, or question.
Khara Lucius (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: